Showing 1 - 13 results of 13 for search 'Christopher Schuster', query time: 0.06s
Refine Results
-
1
-
2
-
3
-
4
Frequency of Envoplakin and Type VII Collagen Autoantibodies and Co-occurrence with Other Skin-specific Autoantibodies in HIV-infected Patients and Uninfected Controls by René Reitermaier, Michael Skoll, Veronique Touzeau-Roemer, Maximilian C. Aichelburg, Adelheid Elbe-Bürger, Wolfgang Bauer, Armin Rieger, Christopher Schuster
Published 2021Connect to this object online.
Book -
5
Itch improvement has a major and comparable effect on the Dermatology Life Quality Index in psoriasis and atopic dermatitis patients by Wolf‐Henning Boehncke, Adam Reich, Sonja Ständer, Julio Hernandez, Can Mert, Susanne Grond, Maria Jose Rueda, Christopher Schuster, Gil Yosipovitch
Published 2024Connect to this object online.
Book -
6
Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of hea... by Andreas Pinter, Kilian Eyerich, Antonio Costanzo, Alyssa Garrelts, Christopher Schuster, Can Mert, Anastasia Lampropoulou, Konstantinos Fotiou, Julia-Tatjana Maul, Kim A. Papp
Published 2024Connect to this object online.
Book -
7
Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24-28 and 48-52 weeks by Alexander Egeberg, Lars Erik Kristensen, Luis Puig, Phoebe Rich, Saxon D. Smith, Alyssa Garrelts, Kyoungah See, Thorsten Holzkaemper, Konstantinos Fotiou, Christopher Schuster
Published 2023Connect to this object online.
Book -
8
Real-World Treatment Patterns and Treatment Benefits among Adult Patients with Atopic Dermatitis: Results from the Atopic Dermatitis Patient Satisfaction and Unmet Need Survey by Matthias Augustin, Antonio Costanzo, Andrew Pink, Julien Seneschal, Christopher Schuster, Can Mert, Mariana Guerreiro, Nicole Tietz, Susanne Grond, Marjolein de Bruin-Weller
Published 2022Connect to this object online.
Book -
9
Efficacy and safety of ixekizumab versus adalimumab in patients with active psoriatic arthritis and moderate-to-severe psoriasis: 52-week results from the randomised SPIRIT-H2H tri... by Kristian Reich, Lars Erik Kristensen, Saxon D. Smith, Phoebe Rich, Christophe Sapin, Soyi Liu Leage, Robert McKenzie, Christopher Schuster, Elisabeth Riedl, Melinda Gooderham
Published 2022Connect to this object online.
Book -
10
Baseline Characteristics and mNAPSI Change from Baseline Scores Through Month 12 for Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with B... by Elisabeth Riedl, Andreas Pinter, Shirin Zaheri, Antonio Costanzo, Alan Brnabic, Bruce Konicek, Robert McKenzie, Anastasia Lampropoulou, Mohamed El Rayes, Natalie Haustrup, Christopher Schuster
Published 2024Connect to this object online.
Book -
11
Time to Loss of Response following Withdrawal of Ixekizumab in Patients with Moderate-to-Severe Psoriasis by Kim Papp, Carle Paul, C. Elise Kleyn, Yu-Huei Huang, Tsen-Fang Tsai, Christopher Schuster, Celine El Baou, Agoston Toth, Elisabeth Riedl, Ulrich Mrowietz
Published 2022Connect to this object online.
Book -
12
Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO) by April W. Armstrong, Elisabeth Riedl, Patrick M. Brunner, Stefano Piaserico, Willie I. Visser, Natalie Haustrup, Bruce W. Konicek, Zbigniew Kadziola, Mercedes Nunez, Alan Brnabic, Christopher Schuster
Published 2024Connect to this object online.
Book -
13
Prevalence of Skin-specific Autoantibodies in HIV-infected Patients and Uninfected Controls by Veronique Touzeau-Roemer, Michael Skoll, Pooja Tajpara, Philip Kienzl, Antonia Wesinger, Simona Saluzzo, Martin Bauer, Maximilian C. Aichelburg, Christine Bangert, Wolfgang Bauer, Georg Stingl, Armin Rieger, Katharina Grabmeier-Pfistershammer, Christopher Schuster
Published 2019Connect to this object online.
Book